What is Bausch Health Companies Inc share price today?

Bausch Health Companies Inc (BHC) share price today is {{live_price}}.

Can Indians buy Bausch Health Companies Inc shares?

Yes, Indians can invest in the Bausch Health Companies Inc (BHC) from India. With INDmoney, you can buy Bausch Health Companies Inc at 0 brokerage. The step-by-step process is as follows: Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes) Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates. Once funds are transferred successfully, you can buy Bausch Health Companies Inc at zero transaction cost.

How can I buy Bausch Health Companies Inc shares from India?

It is very easy to buy Bausch Health Companies Inc from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Bausch Health Companies Inc be purchased?

Yes, you can buy fractional shares of Bausch Health Companies Inc with INDmoney app.

What are the documents required to start investing in Bausch Health Companies Inc stocks?

To start investing in Bausch Health Companies Inc, You will need the following documents: Proof of Identification (PAN, Aadhaar etc) Proof of address (Aadhaar, Voter ID etc) These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Bausch Health Companies Inc

Today’s highest price of Bausch Health Companies Inc (BHC) is {{1_rba_end}}. Today’s lowest price of Bausch Health Companies Inc (BHC) is {{1_rba_st}}.

What is today's market capitalisation of Bausch Health Companies Inc

Today's market capitalisation of Bausch Health Companies Inc BHC is 3.0B

What is the 52 Week High and Low Range of Bausch Health Companies Inc

52 Week High {{rba_end}} 52 Week Low {{rba_st}}

How much percentage Bausch Health Companies Inc is down from its 52 Week High?

Bausch Health Companies Inc (BHC) share price is {{live_price}}. It is down by {{w52lu}}% from its 52 Week High price of {{rba_end}}.

How much percentage Bausch Health Companies Inc is up from its 52 Week low?

Bausch Health Companies Inc (BHC) share price is {{live_price}}. It is up by {{w52hd}}% from its 52 Week Low price of {{rba_st}}.

What are the historical returns of Bausch Health Companies Inc?

1 Month Returns {{1mr}}% 3 Months Returns {{3mr}}% 1 Year Returns {{1yr}}% 5 Years Returns {{5yr}}%

Who is the Chief Executive Officer (CEO) of Bausch Health Companies Inc

Mr. Thomas J. Appio is the current Chief Executive Officer (CEO) of Bausch Health Companies Inc.

Home

US Stocks

Bausch Health Companies Inc

Bausch Health Companies Inc (BHC)

$8.2

-0.01

(-0.12%)▲

Market is closed - opens 7 PM, 02 Jun 2023

Insights on Bausch Health Companies Inc

Decreasing Revenue
Revenue is down for the last 2 quarters, 2.13B → 1.94B (in $), with an average decrease of 9.0% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -410.0M → -201.0M (in $), with an average increase of 104.0% per quarter
Vs ZTS
In the last 1 year, Bausch Health Companies Inc has experienced a drawdown of -14.2%, however Zoetis Inc - Class A resisted the overall trend and outperformed by 11.8%
Vs ZTS
In the last 3 years, Zoetis Inc - Class A has given 17.8% return, outperforming this stock by 75.0%

Performance

$8.03
$8.29
$8.20
2.07%
Downside
Day's Volatility :3.08%
Upside
1.03%
$4.00
$10.23
$8.20
51.22%
Downside
52 Weeks Volatility :60.9%
Upside
19.84%

Returns

Period	Bausch Health Companies Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	-10.95%	0.7%	-6.8%
6 Months	6.62%	-8.3%	-6.0%
1 Year	-14.21%	-1.9%	-4.6%
3 Years	-57.15%	25.3%	25.9%

Highlights

Market Capitalization	3.0B
Book Value	- $2.2
Dividend Share	0.0
Dividend Yield	0.0%
Earnings Per Share (EPS)	-0.97
PEG Ratio	0.63
Wall Street Target Price	13.1

Profit Margin	-4.38%
Operating Margin TTM	16.92%

Return On Assets TTM	3.16%
Return On Equity TTM	-17750.0%

Revenue TTM	8.2B
Revenue Per Share TTM	22.48
Quarterly Revenue Growth YOY	1.4000000000000001%
Gross Profit TTM	5.8B
EBITDA	2.7B
Diluted Eps TTM	-0.97
Quarterly Earnings Growth YOY	1.12

EPS Estimate Current Year	3.29
EPS Estimate Next Year	3.78
EPS Estimate Current Quarter	0.72
EPS Estimate Next Quarter	0.79

Analyst Recommendation

Buy

62%Buy

37%Hold

0%Sell

Based on 8 Wall street analysts offering stock ratings for Bausch Health Companies Inc(by analysts ranked 0 to 5 stars)

Based on 8 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast

What analysts predicted

Upside of 59.76%

Current $8.20

Target $13.10

Company Financials

	FY17	Y/Y Change
Revenue	8.7B	↓ 9.82%
Net Income	2.4B	↓ 199.79%
Net Profit Margin	27.56%	↑ 52.46%

	FY18	Y/Y Change
Revenue	8.4B	↓ 3.94%
Net Income	-4.1B	↓ 272.55%
Net Profit Margin	-49.5%	↓ 77.06%

	FY19	Y/Y Change
Revenue	8.6B	↑ 2.64%
Net Income	-1.8B	↓ 56.89%
Net Profit Margin	-20.79%	↑ 28.71%

	FY20	Y/Y Change
Revenue	8.0B	↓ 6.67%
Net Income	-560.0M	↓ 68.68%
Net Profit Margin	-6.98%	↑ 13.81%

	FY21	Y/Y Change
Revenue	8.4B	↑ 5.07%
Net Income	-948.0M	↑ 69.29%
Net Profit Margin	-11.24%	↓ 4.26%

	FY22	Y/Y Change
Revenue	8.0B	↓ 4.6%
Net Income	-225.0M	↓ 76.27%
Net Profit Margin	-2.8%	↑ 8.44%

	Q4 FY21	Q/Q Change
Revenue	2.2B	↑ 4.03%
Net Income	69.0M	↓ 63.3%
Net Profit Margin	3.14%	↓ 5.77%

	Q1 FY22	Q/Q Change
Revenue	1.9B	↓ 12.66%
Net Income	-69.0M	↓ 200.0%
Net Profit Margin	-3.6%	↓ 6.74%

	Q2 FY22	Q/Q Change
Revenue	1.9B	↑ 1.51%
Net Income	-145.0M	↑ 110.14%
Net Profit Margin	-7.45%	↓ 3.85%

	Q3 FY22	Q/Q Change
Revenue	2.0B	↑ 5.08%
Net Income	399.0M	↓ 375.17%
Net Profit Margin	19.5%	↑ 26.95%

	Q4 FY22	Q/Q Change
Revenue	2.1B	↑ 4.35%
Net Income	-410.0M	↓ 202.76%
Net Profit Margin	-19.2%	↓ 38.7%

	Q1 FY23	Q/Q Change
Revenue	1.9B	↓ 8.95%
Net Income	-201.0M	↓ 50.98%
Net Profit Margin	-10.34%	↑ 8.86%

	FY17	Y/Y Change
Total Assets	37.5B	↓ 13.86%
Total Liabilities	31.6B	↓ 21.65%

	FY18	Y/Y Change
Total Assets	32.5B	↓ 13.35%
Total Liabilities	29.7B	↓ 5.95%

	FY19	Y/Y Change
Total Assets	33.9B	↑ 4.22%
Total Liabilities	32.7B	↑ 10.28%

	FY20	Y/Y Change
Total Assets	31.2B	↓ 7.87%
Total Liabilities	30.6B	↓ 6.52%

	FY21	Y/Y Change
Total Assets	29.2B	↓ 6.4%
Total Liabilities	29.2B	↓ 4.44%

	FY22	Y/Y Change
Total Assets	25.7B	↓ 12.04%
Total Liabilities	25.4B	↓ 13.03%

	Q4 FY21	Q/Q Change
Total Assets	29.2B	↓ 0.17%
Total Liabilities	29.2B	↓ 0.51%

	Q1 FY22	Q/Q Change
Total Assets	29.1B	↓ 0.38%
Total Liabilities	29.2B	↓ 0.02%

	Q2 FY22	Q/Q Change
Total Assets	28.2B	↓ 3.16%
Total Liabilities	27.9B	↓ 4.49%

	Q3 FY22	Q/Q Change
Total Assets	26.3B	↓ 6.65%
Total Liabilities	25.9B	↓ 7.35%

	Q4 FY22	Q/Q Change
Total Assets	25.7B	↓ 2.33%
Total Liabilities	25.4B	↓ 1.7%

	Q1 FY23	Q/Q Change
Total Assets	25.4B	↓ 0.94%
Total Liabilities	25.3B	↓ 0.5%

	FY17	Y/Y Change
Operating Cash Flow	2.3B	↑ 9.73%
Investing Cash Flow	2.9B	↓ 2409.6%
Financing Cash Flow	-5.0B	↑ 152.83%

	FY18	Y/Y Change
Operating Cash Flow	1.5B	↓ 34.45%
Investing Cash Flow	-196.0M	↓ 106.79%
Financing Cash Flow	-1.4B	↓ 72.74%

	FY19	Y/Y Change
Operating Cash Flow	1.5B	↑ 0.0%
Investing Cash Flow	-419.0M	↑ 113.78%
Financing Cash Flow	1.4B	↓ 206.65%

	FY20	Y/Y Change
Operating Cash Flow	1.1B	↓ 25.98%
Investing Cash Flow	-261.0M	↓ 37.71%
Financing Cash Flow	-2.3B	↓ 258.97%

	FY21	Y/Y Change
Operating Cash Flow	1.4B	↑ 28.35%
Investing Cash Flow	409.0M	↓ 256.7%
Financing Cash Flow	-1.5B	↓ 34.05%

	Q4 FY21	Q/Q Change
Operating Cash Flow	24.0M	↓ 95.74%
Investing Cash Flow	-80.0M	↓ 113.61%
Financing Cash Flow	275.0M	↓ 123.77%

	Q1 FY22	Q/Q Change
Operating Cash Flow	-63.0M	↓ 362.5%
Investing Cash Flow	-56.0M	↓ 30.0%
Financing Cash Flow	468.0M	↑ 70.18%

	Q2 FY22	Q/Q Change
Operating Cash Flow	123.0M	↓ 295.24%
Investing Cash Flow	-58.0M	↑ 3.57%
Financing Cash Flow	-630.0M	↓ 234.62%

	Q3 FY22	Q/Q Change
Operating Cash Flow	-1.3B	↓ 1126.83%
Investing Cash Flow	-167.0M	↑ 187.93%
Financing Cash Flow	-36.0M	↓ 94.29%

	Q1 FY23	Q/Q Change
Operating Cash Flow	154.0M	↓ 67.58%
Investing Cash Flow	-78.0M	-
Financing Cash Flow	-142.0M	↓ 48.55%

Technicals Summary

Sell

Neutral

Buy

Bausch Health Companies Inc is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Bausch Health Companies Inc	9.32%	6.62%	-14.21%	-57.15%	-62.82%
Neurocrine Biosciences Inc.	-13.93%	-29.12%	-3.47%	-27.45%	-9.1%
Zoetis Inc.	-9.22%	4.07%	-2.4%	17.83%	90.83%
Viatris Inc.	-2.24%	-18.59%	-24.19%	-44.0%	-44.0%
Catalent, Inc.	-25.72%	-28.72%	-64.37%	-51.42%	-6.08%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Bausch Health Companies Inc	71.75	NA	0.63	3.29	-177.5	0.03	0.0	-2.2
Neurocrine Biosciences Inc.	145.34	145.34	1.87	2.1	0.04	0.08	0.0	17.28
Zoetis Inc.	36.41	36.41	3.53	5.4	0.45	0.13	0.01	9.72
Viatris Inc.	5.8	5.8	NA	2.95	0.09	0.03	0.05	17.45
Catalent, Inc.	15.88	15.88	1.18	1.37	0.09	0.04	0.0	27.29

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Bausch Health Companies Inc	Buy	$3.0B	-62.82%	71.75	-4.38%
Neurocrine Biosciences Inc.	Buy	$8.8B	-9.1%	145.34	4.0%
Zoetis Inc.	Buy	$74.4B	90.83%	36.41	25.59%
Viatris Inc.	Hold	$10.9B	-44.0%	5.8	12.05%
Catalent, Inc.	Buy	$6.5B	-6.08%	15.88	8.62%

Institutional Holdings

ICAHN CARL C
9.55%
Paulson & Company Inc
7.27%
Franklin Resources Inc
4.57%
Goldentree Asset Management LP
4.55%
Natixis SA
4.35%
Hudson Bay Capital Management LP
3.16%

Organization	Bausch Health Companies Inc
Employees	19900
CEO	Mr. Thomas J. Appio
Industry	Health Technology

Bausch Health Companies Inc (BHC)

Insights on Bausch Health Companies Inc

Decreasing Revenue

Increasing Net Profit

Vs ZTS